RxDoctor Payments Data

Bennie Law, MD

Family Medicine · Americus, GANPI 1932170461

Payments from drug & device makers

$1,555in general payments, 2019–2025

Across 92 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$267
  • Novo Nordisk$256
  • GSK$212
  • AstraZeneca$149
  • Sanofi-aventis U.S. LLC$108
  • Lilly USA, LLC$102
  • plus $460 from 12 others

What the payments were for

  • Food & beverage$1,555100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,555 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$117,117
Medicare patients
248
Services billed
7,234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide148$151,935
OzempicSemaglutide144$140,956
JardianceEmpagliflozin90$82,700
EliquisApixaban82$70,714
RybelsusSemaglutide42$59,610
LinzessLinaclotide72$53,690
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$51,130
JanuviaSitagliptin Phosphate51$50,030
MounjaroTirzepatide45$46,656
XareltoRivaroxaban39$39,075
GlyxambiEmpagliflozin/Linagliptin36$37,284
FarxigaDapagliflozin Propanediol26$23,824
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog19$21,314
Janumet XrSitagliptin Phos/Metformin Hcl19$20,842
TradjentaLinagliptin20$20,555

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$256$200,566186 claims
Lilly USA, LLCTrulicity, Mounjaro$102$198,591193 claims
Boehringer IngelheimJardiance, Glyxambi, Tradjenta, Combivent Respimat$97$145,858157 claims
MerckJanuvia, Janumet Xr$74$70,87270 claims
PfizerEliquis$28$70,71482 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix, Arnuity Ellipta$212$68,008110 claims
AbbVieLinzess$14$53,69072 claims
AstraZenecaFarxiga, Symbicort$149$33,77063 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Americus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →